Filing Details
- Accession Number:
- 0001209191-17-045083
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-07-13 17:54:32
- Reporting Period:
- 2017-07-11
- Filing Date:
- 2017-07-13
- Accepted Time:
- 2017-07-13 17:54:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1269021 | Portola Pharmaceuticals Inc | PTLA | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1574591 | Mardi Dier | C/O Portola Pharmaceuticals, Inc. 270 East Grand Avenue South San Francisco CA 94080 | Executive Vp And Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-07-11 | 23,350 | $25.08 | 23,350 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-07-11 | 23,350 | $60.00 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2017-07-11 | 23,350 | $0.00 | 23,350 | $25.08 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
35,390 | 2014-03-26 | 2024-03-26 | No | 4 | M | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2017.